𝐏𝐫𝐢𝐜𝐞 𝐖𝐚𝐭𝐜𝐡™ provides price assessments for Vitamin K3 (Menadione) across top trading regions:
Asia-Pacific
- Vitamin K3 (Menadione) Menadione Sodium Bisulfite (MSB, >98%, Powder) FOB Shanghai, China
- Vitamin K3 (Menadione) Menadione Nicotinamide Bisulfite (MNB, >98%, Powder) FOB Shanghai, China
- Vitamin K3 (Menadione) Menadione Sodium Bisulfite (MSB, >98%, Powder) Ex-Zhejiang, China
- Vitamin K3 (Menadione) Menadione Nicotinamide Bisulfite (MNB, >98%, Powder Ex-Zhejiang, China
Note: In assessments structured as CIF [Importing Port] (Exporting Country), the country mentioned in brackets indicates the primary origin of supply (exporting country), while the named port refers to the destination port in the importing country. Other Incoterms (FOB, FD, EXW, etc.) should be interpreted in accordance with standard international trade definitions.
Vitamin K3 (Menadione) Price Trend Q4 2025
In Q4 2025, the Vitamin K3 (Menadione) market has maintained a bearish trend across both Menadione Sodium Bisulfite (MSB) and Menadione Nicotinamide Bisulfite (MNB) grades, with prices declining by around 4-6% on a quarter-on-quarter basis. The downturn has been driven by subdued demand from feed and premix manufacturers, along with ample domestic supply and competitive pricing among producers. Market participants have continued to adopt cautious procurement strategies, while stable production rates and sufficient inventory levels have further contributed to downward pressure. Overall, the market sentiment has remained weak during the quarter, with limited export momentum and no significant supply constraints to support price recovery.
China: Vitamin K3 (Menadione) Export prices FOB Shanghai, China
In Q4 2025, Vitamin K3 (Menadione) Menadione Sodium Bisulfite (MSB, >98%, Powder) prices in China have declined, reflecting a 4.10% quarter-on-quarter decrease. Similarly, Vitamin K3 (Menadione) Menadione Nicotinamide Bisulfite (MNB, >98%, Powder) prices in China have also softened, registering a 5.51% decline during the quarter. The decreases have been attributed to muted demand from animal nutrition sectors, sufficient supply availability, and competitive domestic offers.
The Vitamin K3 (Menadione) price trend in China has remained moderate but insufficient to support price stabilization, with prevailing supply-demand dynamics expected to continue influencing pricing trends into the next quarter. In December 2025, Vitamin K3 (Menadione) Menadione Sodium Bisulfite (MSB, >98%, Powder) prices in China increased with 0.53% and Vitamin K3 (Menadione) Menadione Nicotinamide Bisulfite (MNB, >98%, Powder) prices in China showed increased of 2.50% as prices have shown signs of stabilization at lower levels as buying interest has gradually improved and inventory pressures have eased slightly.

